background image

Paid Clinical Trials Bellevue

Discover 602 paid clinical trials in Bellevue, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.

for
Diabetic Foot Ulcer (DFU), Amnio-Maxx
Location: 8 recruiting locations
Sponsor: Royal Biologics

Sex: All

Age: 18+

Code: NCT07209475

Recruiting
FeaturedActive & Responsive

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 10 - 17

Code: NCT06372964

Phase3, Recruiting
Active & Responsive

WATER IV Prostate Cancer

for
Localized Prostate Cancer
Location: 19 recruiting locations
Sponsor: PROCEPT BioRobotics

Sex: Male

Age: 45+

Code: NCT06651632

Recruiting
Active & Responsive

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

for
Age-Related Macular Degeneration, Geographic Atrophy
Location: 10 recruiting locations
Sponsor: VisionCare, Inc.

Sex: All

Age: 65+

Code: NCT05438732

Recruiting
Active & Responsive

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

for
Colonic Neoplasms, Neoplasms, Colon
Location: 32 recruiting locations
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05855200

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)

for
Urothelial Carcinoma,
Location: 2 recruiting locations
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT06396533

Recruiting
Active & Responsive

Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer

for
Hormone Receptor Positive Breast Carcinoma,
Location: 3 recruiting locations
Sponsor: Marina N Sharifi

Sex: All

Age: 18+

Code: NCT04762979

Phase2, Recruiting
Active & Responsive

Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

for
Lymphoma, B-Cell
Location: 7 recruiting locations
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT04884035

Phase1, Recruiting
Active & Responsive

Improving Physical Activity With Cognitive Impairment

for
Mild Cognitive Impairment, Caregiver Burnout
Location: 1 recruiting location
Sponsor: Creighton University

Sex: All

Age: 50 - 70+

Code: NCT05370118

Recruiting
Active & Responsive

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: 120 recruiting locations
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting